<Suppliers Price>

4-Chloro-5-sulfamoylanthranilic Acid

Names

[ CAS No. ]:
3086-91-7

[ Name ]:
4-Chloro-5-sulfamoylanthranilic Acid

[Synonym ]:
4-Chloro-5-sulfamoylanthranilic acid
2-AMINO-5-AMINOSULFONYL-4-CHLOROBENZOIC ACID
4-chloro-5-sulphamoyl anthranilic acid
Desfurylmethylfurosemide
Saluamine
2-amino-4-chloro-5-sulfamoyl-benzoic acid
Furosemide Related Compound B
EINECS 221-408-7
4-chloro-5-sulfamoyl-anthranilic acid
4-Chloro-5-sulfanilanthranilic acid

Chemical & Physical Properties

[ Density]:
1.726g/cm3

[ Boiling Point ]:
549.2ºC at 760mmHg

[ Melting Point ]:
267°C (dec.) (lit.)

[ Molecular Formula ]:
C7H7ClN2O4S

[ Molecular Weight ]:
250.65900

[ Flash Point ]:
286ºC

[ Exact Mass ]:
249.98200

[ PSA ]:
131.86000

[ LogP ]:
2.63010

[ Index of Refraction ]:
1.665

Safety Information

[ Symbol ]:

GHS07

[ Signal Word ]:
Warning

[ Hazard Statements ]:
H315-H319-H335

[ Precautionary Statements ]:
P305 + P351 + P338

[ Hazard Codes ]:
N

[ RIDADR ]:
NONH for all modes of transport

[ HS Code ]:
2935009090

Synthetic Route

Precursor & DownStream

Customs

[ HS Code ]: 2935009090

[ Summary ]:
2935009090 other sulphonamides VAT:17.0% Tax rebate rate:9.0% Supervision conditions:none MFN tariff:6.5% General tariff:35.0%

Articles

The use of HPLC to elucidate the metabolism and urinary excretion of furosemide and its metabolic products.

Acta Pharmacol. Toxicol. (Copenh.) 49(3) , 223-9, (1981)

Three principles for the use of HPLC with spectrophotometric detection to determine the concentration of furosemide and of 4-chloro-5-sulfamoyl anthranilic acid (CSA) were studied. A reversed phase mi...

The binding of furosemide to serum proteins in elderly patients: displacing effect of phenprocoumon.

Acta Pharmacol. Toxicol. (Copenh.) 47(3) , 202-7, (1980)

The percentual binding of furosemide (5 micrograms/ml) was slightly but significantly lower in serum from elderly patients than in serum from normal blood donors (96.5 +/- 0.7 versus 97.9 +/- 0.3). A ...

Furosemide accelerates gentamicin accumulation in cultured renal cells (LLC-PK1 cells).

Nephron 53(2) , 138-41, (1989)

Furosemide is known to potentiate gentamicin nephrotoxicity. The mechanism of potentiation is unclear. In our previous studies, we demonstrated that furosemide enhanced gentamicin accumulation in rabb...


More Articles


Related Compounds

The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.